Aceclofenac, Paracetamol & Serratiopeptidase Tablets
Aceclofenac, Paracetamol & Serratiopeptidase Tablets
Triple-Action NSAID with Proteolytic Enzyme

Aceclofenac, Paracetamol & Serratiopeptidase Tablets

Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Aceclofenac, Paracetamol & Serratiopeptidase Tablets (Apraflex SP). High-quality, reliable, affordable medicine.

Formulation Tablets
Standard WHO-GMP Certified Quality
Supply Type Global Export & Institutional Supply
Finished Commercial Brand

Available finished formulation under our brand name APRAFLEX SP.

View Commercial Product Details
WHO-GMP Certified
Global Export Ready
Quality Assured

Formulation Insights

Comprehensive Medical Overview

Aceclofenac, Paracetamol & Serratiopeptidase Tablets

Classification: Triple-Action NSAID with Proteolytic Enzyme

About Aceclofenac, Paracetamol & Serratiopeptidase Tablets

A potent triple-action therapeutic combination of Aceclofenac, Paracetamol, and Serratiopeptidase (a proteolytic enzyme) designed for severe pain, rapid reduction of edema, soft tissue inflammation, and post-traumatic injury.

Aceclofenac, Paracetamol & Serratiopeptidase Tablets (Apraflex SP) Manufactured by Aprazer Healthcare

Apraflex SP is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.